PFE : Analysis & Opinions

  • Showing 1-100 of 151 items
  • 1
  • 2
  • >>
  1. Pfizer Inks a $1.6 Billion Deal with AstraZeneca

    August 25, 2016
    In light of its recent acquisition activity, Pfizer's (NYSE: PFE) latest asset purchase might seem small, but it's nevertheless ...
  2. Top 6 Pharmaceutical Companies Globally

    August 23, 2016
    Johnson & Johnson leads the pack in both market cap and revenue.
  3. American Funds Shedding Dividend Payers for Growth (BABA, MO)

    August 23, 2016
    American Funds, with $1.3T in AUM, is shifting towards a growth strategy.
  4. Top 10 Shareholders of Pfizer (PFE)

    August 23, 2016
    As of 2016, approximately 72% of Pfizer's 6.19 billion outstanding shares are owned by [mutual funds] and institutional investors.
  5. Pfizer Acquires Medivation for $14 Billion (PFE, MDVN)

    August 21, 2016
    Pfizer has agreed to pay $81.50 per share for Medivation, implying a premium value compared with the $52.50 offer made by ...
  6. Big Sell-Off of Pfizer Amid Merger Collapse (PFE, AGN)

    August 19, 2016
    The collapse of the planned merger of Pfizer and Allergan triggered major waves in stock holdings among the country's top ...
  7. Who Is Driving Pfizer's Management Team? (PFE)

    August 19, 2016
    Pfizer Inc.'s management team is led by Ian C. Read, Frank D'Amelio and Freda C. Lewis-Hall, all veterans with decades of ...
  8. Allergan Features Prominently in Q2 2016 (AGN, PFE)

    August 17, 2016
    13F filings from top investors show that the pharmaceutical company was a big mover in Q2.
  9. JANA Partners Invests in Time Inc., Exits Pfizer (TIME, PFE)

    August 16, 2016
    JANA Partners enters into a new stake in Time Inc. What could it reveal about the hedge fund's future plans?
  10. Pfizer: 7 Secrets You Didn't Know (PFE)

    August 8, 2016
    The history of Pfizer is more interesting than you know, learn some little-known facts about the pharmaceuticals company ...
  11. Allergan's Q2 Earnings Beat Boosted by Botox

    August 8, 2016
    With the failed Pfizer merger out of the way, Allergan appears focused and is looking once again to maximize growth in its ...
  12. Pfizer Stock Trades Ex-Dividend (PFE)

    August 2, 2016
    Shares declined Tuesday, falling more than 2% despite the company reporting Q2 results that beat Wall Street estimates on ...
  13. Pfizer's Q2 Earnings, Revenue Beat Not Good Enough (PFE)

    August 2, 2016
    Pfizer shares are falling more than 2% despite the company reporting Q2 earnings results that beat Wall Street estimates ...
  14. Pfizer Price Levels To Watch After Earnings (PFE)

    August 1, 2016
    Pfizer has rallied to a 12-year high and could add to gains after Tuesday's earnings report but is extremely overbought and ...
  15. Pfizer Earnings Coming Up: What to Expect? (PFE)

    August 1, 2016
    Wall Street expects another solid quarter for Pfizer, which has topped consensus estimates on both the top and bottom lines ...
  16. Top 5 Corporate Donors in Big Pharma (GILD, MRK)

    July 29, 2016
    Gilead Sciences, Merck and Pfizer were among the biggest corporate cash donors from the drug and health care sector last ...
  17. Pfizer Exits Brazil: Teva Is Suitor (PFE, TEVA)

    July 29, 2016
    Pfizer is planning to exit the Brazilian market as it puts its generic drug joint venture stake up for sale. Teva and Mylan ...
  18. Pfizer, Celgene Pursue Medivation (PFE, CELG)

    July 6, 2016
    Sanofi isn't the only one interested in Medivation. Pfizer and Celgene also signed confidentiality agreements.
  19. Why Pfizer Just Bet $350 Million On China (PFE)

    June 29, 2016
    The drug giant announced plans to invest $350 million on a China-based plant for biotechnology drugs.
  20. Pfizer to Build $350M Biotech Center in China (PFE)

    June 28, 2016
    Pfizer Inc. is investing $350M to build its first biotech center in Asia. What’s the real value proposition for Pfizer beyond ...
  21. Pfizer Stock Rises Despite Price Target Cut (PFE)

    June 21, 2016
    Shares of Pfizer rose as much as 1.37% Monday, reaching a session high of $34.69 even though the drug giant saw its price ...
  22. Oracle Scores Another Cloud Services Win

    June 20, 2016
    By virtually every measure, the cloud market is poised to explode in the coming months and years. One of the fastest-growing ...
  23. 3 Mutual Funds Poised to Perform in the Future (VGENX, FSPHX)

    June 19, 2016
    Learn about sector weightings in growth mutual funds versus the benchmark and how three funds are positioned to profit from ...
  24. Avoid Betting on These Acquisition Target Stocks (PFE, AGN)

    June 16, 2016
    Many target stocks high on acquirers list are trading at deep discounts. Here’s why investors should avoid them.
  25. Is Investment Banking Peaking? (PFE, AGN)

    June 15, 2016
    Learn about the numerous challenges facing investment banking and explore whether the industry is peaking.
  26. How M&A Breakups Are Hurting Investment Banks' Profits (PFE, ...

    June 14, 2016
    Discover what happens when mergers and acquisitions fail. Learn about three major deals that have fallen through in 2016 ...
  27. The Share Buyback Report: Health Care Sector (PFE, JNJ)

    June 3, 2016
    Analyze health care sector share repurchase data to identify trends. Determine which factors influence volume and which companies ...
  28. Biotech Stocks: Are They Back?

    June 1, 2016
    The bearish trends over the past year have started to reverse themselves which has benefted the biotech industry
  29. 5 Companies With Huge Cash Flow (AAPL,VZ,MSFT,WMT)

    June 1, 2016
    These five companies have major cash flow which makes them good long-term bets.
  30. Allergan Stock Rises on Carl Icahn's Stake (AGN, PFE)

    June 1, 2016
    The Botox maker got a much-needed dose of confidence Tuesday when the market learned that activist investor Carl Icahn had ...
  31. 3 ETFs Affected by the Failed Pfizer-Allergan Merger (PFE, AGN)

    May 28, 2016
    Discover three ETFs that were affected by the failed Pfizer and Allergan acquisition, and learn about the performances and ...
  32. VHT: Vanguard Health Care ETF Performance Analysis

    May 26, 2016
    Discover how the Vanguard Health Care ETF performed through bear and bull markets, and learn which holding is trouncing the ...
  33. Biotech ETFs: Why Valeant May Cause Contagion Risk (VRX)

    May 26, 2016
    Learn about Valeant Pharmaceutical's scandal that caused its stock to plunge over 90%, and why biotech ETF investors should ...
  34. CF Industries Drops Planned Purchase of OCI

    May 24, 2016
    A federal crackdown on tax inversion mergers has effectively killed a planned acquisition by fertilizer maker CF Industries' ...
  35. Pfizer Bets Big on Eczema With Anacor Acquisition

    May 23, 2016
    Pfizer seems to have made the right bet on Anacor to capture the present day $4 billion eczema medicine market.
  36. XenoPort Stock Rises Nearly 60% on Takeover News

    May 23, 2016
    It's a fine time to be a shareholder in biotech company XenoPort (NASDAQ: XNPT). The company revealed Monday that it has ...
  37. Pfizer Buys Anacor Pharmaceuticals For $5.2B (PFE, ANAC)

    May 17, 2016
    Pfizer, which last month ended its bid for Allergan, is looking to capitalize on Anacor's experimental gel used to treat ...
  38. Pfizer to Pay 55% Premium to Acquire Anacor

    May 16, 2016
    The share price of biotech company Anacor Pharmaceuticals (NASDAQ: ANAC) rose by nearly 60% Monday following news that it ...
  39. Allergan Stock Falls to New Low Ahead of Earnings (AGN, PFE)

    May 9, 2016
    Wall Street expects the maker of cosmetic injection Botox to deliver year-over-year declines in both revenue and profits.
  40. FKINX: Franklin Income Performance Case Study

    May 3, 2016
    Learn about the Franklin Income Fund's history, trends and performance for each quarter over the past decade.
  41. Pfizer Stock Rises Ahead of Earnings (PFE, AGN)

    May 2, 2016
    It turns out Pfizer might not have needed Allergan after all, given that PFE shares have surged 9% and 7.3% in the respective ...
  42. 6 Reasons to Watch Kythera Biopharm Inc. (AGN, PFE)

    May 1, 2016
    Discover why the Russell 2000 and other investment indexes believe California-based Kythera Biopharmaceuticals Inc. is a ...
  43. Global Health Care Technology: 5 Key Industry Players (JNJ, GSK)

    April 27, 2016
    Discover how to analyze which of these top five key global health care technology industry players best suit your portfolio ...
  44. The 3 Largest Health Care ETFs (XLV, IBB)

    April 25, 2016
    Find out which exchange-traded funds (ETFs) are the largest in terms of total assets under management (AUM) in the health ...
  45. Valeant vs. Abbott Labs: Which Is Better for My Portfolio? (VRX, ...

    April 16, 2016
    Explore the differences between Abbott Laboratories and Valeant Pharmaceuticals, as well as which stock is the best addition ...
  46. Singer Gets Better End of AGN-PFE Deal Implosion

    April 12, 2016
    Paul Singer increased his stake in Allergen by 204.75% in the fourth quarter. How will this impact his portfolio since the ...
  47. Pfizer CEO: Let Us Invest in the U.S. (AGN, PFE)

    April 7, 2016
    Ian Read, Chairman and CEO of Pfizer, published an op-ed in the Wall Street Journal Wednesday, in which he defended the logical ...
  48. Allergan's Fall Hits Hedge Funds Hard (AGN, PFE)

    April 6, 2016
    When shares in Allergan dropped 14.8% to $236.55 on Tuesday, not everyone realized how much – and how many – hedge funds ...
  49. FAGIX: Fidelity Capital & Income Fund's Top 5 Holdings Analysis

    April 6, 2016
    Evaluate the top five holdings of the Fidelity Capital & Income Fund, and study the basics and recent performance of the ...
  50. Pfizer Withdraws Merger Bid With Allergan (AGN, PFE)

    April 6, 2016
    Pfizer has come to realize the U.S. Treasury Department's new stance with inversions: "Over my dead body."
  51. Allergan Now Trades Cheaper Than Its Standalone Value

    April 5, 2016
    Shibani Malhotra of Nomura thinks Allergan plc Ordinary Shares (NYSE: AGN) is compelling, despite treasury notice that threatens ...
  52. The Market In 5 Minutes: Tuesday, April 5, 2016

    April 5, 2016
    Below is a tool used by the Benzinga News Desk each trading day -- it's a look at everything happening in the market, in ...
  53. Allergan Crushed as Tax Inversion Rules Threaten PFE Deal (AGN, ...

    April 5, 2016
    Given the army of lawyers, not to mention lobbyists, on their respective payrolls, Allergen and Pfizer are not likely to ...
  54. The Most Shorted Stocks and ETF (PFE,SPY,CHK,S)

    March 29, 2016
    These stocks and ETF are heavily shorted and have been rallying at breakneck speed. Will it continue?
  55. Pfizer Short Interest Continues to Rise (PFE)

    March 29, 2016
    Dating back to March 2015 the only ones to have made money on PFE stock have been the short sellers. Do they know something ...
  56. VGHCX: Portfolio Trends in 2016

    March 25, 2016
    Evaluate the composition of the Vanguard Health Care Fund, and study how the fund's makeup has evolved over the previous ...
  57. 3 S&P 500 Stocks to Sell Short at the 50-Day EMA

    March 21, 2016
    The 50-day EMA works well with other indicators to identify short sale opportunities with market laggards.
  58. (VHT) Vanguard Healthcare ETF: Top 5 Holdings

    March 19, 2016
    Identify the top five holdings in the Vanguard Health Care exchange-traded fund (ETF), and evaluate each holding's business ...
  59. 4 Defensive ETFs Worth Your While (VHT, PGX)

    March 19, 2016
    Find out which top exchange-traded funds (ETFs) would be well worth your consideration when deploying a defensive investment ...
  60. (XLV) Healthcare SPDR ETF: Top 5 Holdings

    March 18, 2016
    Discover the top five stocks in the Health Care Select Sector SPDR Fund, and learn if they can help power your portfolio ...
  61. The 5 Highest Paid Executives in the Healthcare Sector (AGN, ...

    March 18, 2016
    Discover who the highest paid executives in the health care sector are and how much they make, while the cost of health care ...
  62. The 3 Biggest Healthcare Stocks in the S&P 500 ETF (SPY, JNJ)

    March 17, 2016
    Discover the three biggest health care companies in the SPY ETF, and learn how they could power your portfolio performance ...
  63. 5 Mutual Funds for Dividend Investors from Morningstar (VDIGX, ...

    March 16, 2016
    Find out which five highly rated dividend funds are Morningstar favorites for their strong yields and overall performance ...
  64. Healthcare Sector: Industries Snapshot (XLV, JNJ)

    March 15, 2016
    Discover the six industries that make up the health care sector in the Standard and Poor's 500, and learn which companies ...
  65. 4 Reasons Behind Bill Ackman's Purchase of Zoetis Stock (ZTS, ...

    March 15, 2016
    Find out the reasons behind activist hedge fund manager Bill Ackman's 10% stake in Zoetis, Inc., and learn his plans for ...
  66. J&J's Partnership with IBM Could Turn Profitable (JNJ, IBM)

    March 12, 2016
    Learn why Johnson & Johnson teamed up with IBM, and which patient mobile apps will be part of their medical data analysis ...
  67. Is Big Pharma Under Pressure in 2016? (JNJ, GSK)

    March 8, 2016
    Find out why large pharmaceutical companies are coming under pressure by investors to break themselves up into smaller companies.
  68. Analyzing Johnson & Johnson's Return on Equity (JNJ, PFE)

    March 6, 2016
    Learn about Johnson & Johnson's recent return on equity, what has driven the recent trends, and how it compares to competitors ...
  69. Analyzing Pfizer's Return on Equity (ROE) (PFE)

    March 5, 2016
    Analyze the return on equity (ROE) of Pfizer and understand how changes in the company's net margin have driven its ROE up ...
  70. Pfizer's 3 Key Financial Ratios (PFE)

    February 29, 2016
    Learn about three important financial ratios that help understand Pfizer, Inc. business and analyze the company's financial ...
  71. Is Pfizer Stock Suitable for Your IRA or Roth IRA? (PFE)

    February 28, 2016
    Discover why Pfizer's suitability in a Traditional IRA or Roth IRA depends on your interpretation of the company's current ...
  72. Don't Freak Out Over Black Swans; Be Prepared

    February 11, 2016
    Could 2016 be a big year for black swans? Who knows? Here's what black swans are, how they can devastate the unprepared, ...
  73. Allergan: An Activist Investment Analysis (AGN,VRX)

    January 28, 2016
    Read about the activist investor campaign against Allergan by Bill Ackman. See how Ackman partnered with another drug company ...
  74. How the New Allergan Plc Will Make Money

    January 14, 2016
    Allergan plc is not only enormous, it's about to more than double in size. Here's why and how.
  75. Healthcare Stocks: Are These 2016's Best?

    January 13, 2016
    Healthcare stocks aren't likely to hold up as well as you think, but these three stocks could offer resiliency.
  76. The Biggest M&A Deals of 2015

    January 5, 2016
    Here is a summary of 2015 M&A activity and a look ahead at 2016.
  77. 5 Big M&A deals in 2015 (PFE, AGN)

    December 23, 2015
    Learn how these mergers and acquisitions helped make 2015 a boom year for M&A deals, with the total value of the companies ...
  78. Top 3 NYSE Listed Stocks for 2016 (BABA, PFE)

    December 23, 2015
    Learn about some of the stocks listed on the NYSE that may setting up for a big year in 2016. See how Alibaba has underperformed ...
  79. The World's Top 10 Biotechnology Companies (JNJ, ROG.VX)

    December 22, 2015
    Learn how the marriage of science and technology is changing the world of medicine and creating some of the largest multinational ...
  80. AstraZeneca Makes a $575 Million Acquisition (AZN, PFE)

    December 16, 2015
    Pharmaceutical giant AstraZeneca (NYSE: AZN) is shoring up its presence in a key segment. On Wednesday, the company announced ...
  81. The Top 5 Dividend Paying Healthcare Stocks for 2016 (JNJ, PFE)

    December 8, 2015
    Discover the top five dividend health care stocks for 2016, including two pharmaceutical giants and two newer dividend stocks ...
  82. M&A Hits a Record in 2015

    December 4, 2015
    2015 has been a record year for mergers and acquisitions as M&A activity hit record levels, fuelled by consolidation in various ...
  83. Retail Investors May Face Capital Gains Tax on Pfizer Allergan ...

    November 30, 2015
    The Pfizer-Allergan merger may end up costing retail investors a pretty penny, but they may be able to minimize their losses. ...
  84. The Biggest Risks of Investing in Pfizer Stock (PFE)

    November 25, 2015
    Learn the biggest potential risks that may affect the price of Pfizer's stock, complete with a fundamental analysis and review ...
  85. Why Are Pfizer And Allergan Talking About A Split Even Before ...

    November 24, 2015
    The proposed merger between Pfizer and Allergan might be headed towards a split in the future. Why?
  86. Positive GDP Number Increases Chance of Rate Hike

    November 24, 2015
    The chances for a December hike in interest rates became stronger this morning with an uptick in U.S. GDP numbers during ...
  87. Pfizer-Allergan Merger Makes Biggest Firm by Sales

    November 23, 2015
    On November 22, 2015, America’s Pfizer and Ireland’s Allergan received their board of directors’ approval to merge in what ...
  88. New Treasury Rules Won't Stop Corporate Inversions (PFE, AGN)

    November 20, 2015
    The US Treasury Department unveiled new rules to curb corporate inversions. But, they may not be enough.
  89. Pfizer and Allergan Talk Mammoth Healthcare Deal

    November 19, 2015
    Pharmaceutical giant Pfizer Inc. is in talks with Botox maker Allergan Plc, to buy the latter in a deal worth $150 billion.
  90. Pfizer - Allergan: Will This Deal Happen? (PFE, AGN)

    October 30, 2015
    The question for investors is: Will this deal happen?
  91. Target Fires First Shot in Holiday Wars at Wal-Mart

    October 30, 2015
    In a move that has threatened retail giant WalMart (WMT), Target (TGT) has announced that it will offer free shipping and ...
  92. The 5 Best Dividend Stocks in the Healthcare Sector (GSK, ABBV)

    October 7, 2015
    Learn about the top five dividend stocks of companies operating in the health care sector that generate substantial cash ...
  93. Are Drug Price Controls Viable in the U.S.? (IPXL, ABBV)

    September 24, 2015
    Are price controls on pharmaceuticals viable in the U.S.? What effect would they have on existing drug companies and their ...
  94. Pfizer Stock Is Like An Extended Release Drug

    August 12, 2015
    Pfizer is a leading research-driven pharmaceutical company, but how good is its financial health?
  95. Europe Regulator Approves Pfizer Buyout of Hospira (HSP, PFE)

    August 7, 2015
    Pfizer (NYSE: PFE) has gotten the green light from Europe's antitrust regulator to acquire fellow pharmaceutical Hospira ...
  96. 3 Reasons Pfizer Stock Could Rise (PFE)

    June 19, 2015
    Pfizer (NYSE: PFE) is truly facing a challenge of unprecedented magnitude at the moment. While patent issues are something ...
  97. Most Important Mergers And Acquisitions Of 2015

    June 15, 2015
    Nearly halfway through the year, 2015 is proving to be a big one for mergers and acquisitions.
  98. 3 Reasons Pfizer Stock Could Fall (PFE)

    June 12, 2015
    Pharmaceutical giant Pfizer (NYSE: PFE) has been something of an anomaly over the past couple of years. Despite facing an ...
  99. Billionaire Phillip Frost Is at It Again (OPK, BRLI)

    June 8, 2015
    Over the past 40 years, Phillip Frost became one of the most respected entrepreneurs in healthcare by cobbling together ...
  100. Pfizer CEO: The Story Behind Ian Read (PFE, AZN)

    June 3, 2015
    Learn about the rise of Ian Read, the CEO of Pfizer. Pfizer is one of the most profitable and largest pharmaceutical companies ...
  • Showing 1-100 of 151 items
  • 1
  • 2
  • >>
Trading Center